Evidence map›Paper›PMID 35308284›Full record

ArticleFrontiers in nutrition2022

Effects of Diabetes on Inflammatory Status and Prognosis in Cancer Patients.

Xiangliang Liu, Kaiwen Zheng, Wei Ji, Wenxin Zhang, Yuguang Li, Mingyang Liu, Jiuwei Cui, Wei Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Diabetes and Cancer: A Twisted Bond.Oncology reviews · 2024
    Review
  2. Article
  3. Endoplasmic Reticulum Stress in Renal Cell Carcinoma.International journal of molecular sciences · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiangliang LiuCancer Center, The First Hospital of Jilin University, Changchun, China.
Kaiwen ZhengCancer Center, The First Hospital of Jilin University, Changchun, China.
Wei JiCancer Center, The First Hospital of Jilin University, Changchun, China.
Wenxin ZhangDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Yuguang LiCollege of Instrumentation and Electrical Engineering, Jilin University, Changchun, China.
Mingyang LiuCollege of Instrumentation and Electrical Engineering, Jilin University, Changchun, China.
Jiuwei CuiCancer Center, The First Hospital of Jilin University, Changchun, China.
Wei LiCancer Center, The First Hospital of Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CNZhongnan Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer and diabetes mellitus (DM) are prevalent, but there still a lack of convinced evidence clearly explaining the extent of the effect of diabetes in cancer. Data and Methods: Clinical data of 2,929 cancer patients were collected. Diabetes were diagnosed according to the Diabetes Diagnosis and Treatment Criteria. BMI was classified by the BMI standards for Chinese adults published by the Working Group on Obesity. All involved patients were classified into the non-DM group and DM group. The Kaplan-Meier curve, log-rank test and Cox regression analyses were used to perform survival analysis. Results: Compared with non-DM patients, OS in DM patients was significant shorter in lung cancer (HR = 2.076, Conclusions: Patients with diabetes tend to combine worse body composition and inflammation status, and that glycemic control can ameliorate the impairment of diabetes to some extent.

Indexed as

BMIcancerdiabetesinflammationprognosis

Identifiers

PMID35308284
PMCPMC8931397
OpenAlexW4214932525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.